BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31359272)

  • 1. Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.
    Blakely AM; Raoof M; Ituarte PHG; Fong Y; Singh G; Lee B
    Ann Surg Oncol; 2019 Nov; 26(12):4008-4015. PubMed ID: 31359272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors.
    Blakely AM; Lafaro KJ; Li D; Kessler J; Chang S; Ituarte PHG; Lee B; Singh G
    Neuroendocrinology; 2020; 110(5):384-392. PubMed ID: 31401633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).
    Rault-Petit B; Do Cao C; Guyétant S; Guimbaud R; Rohmer V; Julié C; Baudin E; Goichot B; Coriat R; Tabarin A; Ramos J; Goudet P; Hervieu V; Scoazec JY; Walter T
    Ann Surg; 2019 Jul; 270(1):165-171. PubMed ID: 29557879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors.
    Raoof M; Dumitra S; O'Leary MP; Singh G; Fong Y; Lee B
    Dis Colon Rectum; 2017 Jul; 60(7):674-681. PubMed ID: 28594716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
    Nesti C; Bräutigam K; Benavent M; Bernal L; Boharoon H; Botling J; Bouroumeau A; Brcic I; Brunner M; Cadiot G; Camara M; Christ E; Clerici T; Clift AK; Clouston H; Cobianchi L; Ćwikła JB; Daskalakis K; Frilling A; Garcia-Carbonero R; Grozinsky-Glasberg S; Hernando J; Hervieu V; Hofland J; Holmager P; Inzani F; Jann H; Jimenez-Fonseca P; Kaçmaz E; Kaemmerer D; Kaltsas G; Klimacek B; Knigge U; Kolasińska-Ćwikła A; Kolb W; Kos-Kudła B; Kunze CA; Landolfi S; La Rosa S; López CL; Lorenz K; Matter M; Mazal P; Mestre-Alagarda C; Del Burgo PM; van Dijkum EJMN; Oleinikov K; Orci LA; Panzuto F; Pavel M; Perrier M; Reims HM; Rindi G; Rinke A; Rinzivillo M; Sagaert X; Satiroglu I; Selberherr A; Siebenhüner AR; Tesselaar MET; Thalhammer MJ; Thiis-Evensen E; Toumpanakis C; Vandamme T; van den Berg JG; Vanoli A; van Velthuysen MF; Verslype C; Vorburger SA; Lugli A; Ramage J; Zwahlen M; Perren A; Kaderli RM
    Lancet Oncol; 2023 Feb; 24(2):187-194. PubMed ID: 36640790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of Excellence.
    Holmager P; Willemoe GL; Nielsen K; Grøndahl V; Klose M; Andreassen M; Langer SW; Hansen CP; Kjær A; Federspiel BH; Knigge U
    Eur J Surg Oncol; 2021 Jun; 47(6):1357-1363. PubMed ID: 33589240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lymph node metastases and right hemicolectomy on outcomes in appendiceal neuroendocrine tumours (aNETs).
    Alabraba E; Pritchard DM; Griffin R; Diaz-Nieto R; Banks M; Cuthbertson DJ; Fenwick S
    Eur J Surg Oncol; 2021 Jun; 47(6):1332-1338. PubMed ID: 33004273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging the Current Risk Factors of Appendiceal Neuroendocrine Neoplasms: Can They Accurately Predict Local Lymph Nodal Invasion? Results from a Large Case Series.
    Galanopoulos M; McFadyen R; Drami I; Naik R; Evans N; Luong TV; Watkins J; Caplin M; Toumpanakis C
    Neuroendocrinology; 2019; 109(2):179-186. PubMed ID: 31060039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma.
    Shannon AB; Goldberg D; Song Y; Paulson EC; Roses RE; Fraker DL; Kelz RR; Miura J; Karakousis GC
    J Surg Oncol; 2020 Sep; 122(3):399-406. PubMed ID: 32346885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-incision laparoscopic ileocecal resection in a 10-year-old child with appendiceal neuroendocrine tumor.
    Goto A; Matsuhashi N; Takahashi T; Sato Y; Hirata S; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Yoshida K
    World J Surg Oncol; 2019 Nov; 17(1):197. PubMed ID: 31771590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
    Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features Associated With Metastases Among Well-Differentiated Neuroendocrine (Carcinoid) Tumors of the Appendix: The Significance of Small Vessel Invasion in Addition to Size.
    Kleiman DA; Finnerty B; Beninato T; Zarnegar R; Nandakumar G; Fahey TJ; Lee SW
    Dis Colon Rectum; 2015 Dec; 58(12):1137-43. PubMed ID: 26544810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
    Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
    Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors.
    Landry JP; Voros BA; Ramirez RA; Boudreaux JP; Woltering EA; Thiagarajan R
    Ann Surg Oncol; 2021 Feb; 28(2):751-757. PubMed ID: 32691337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
    Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
    J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Russell MC; Cardona K; Sullivan PS; Maithel SK
    J Surg Oncol; 2019 Nov; 120(6):932-939. PubMed ID: 31448820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on Appendiceal Neuroendocrine Tumors.
    Andrini E; Lamberti G; Alberici L; Ricci C; Campana D
    Curr Treat Options Oncol; 2023 Jul; 24(7):742-756. PubMed ID: 37140773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter?
    Gahagan JV; Whealon MD; Phelan MJ; Mills S; Pigazzi A; Stamos MJ; Nguyen NT; Carmichael JC
    J Am Coll Surg; 2017 Jul; 225(1):69-75. PubMed ID: 28188838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.